THREAD:
Initial data from the first 47 validated cases in the Global Registry
Initial data from the first 47 validated cases in the Global Registry
Most have RA (38%), SLE (17%) and PsA (11%). 75% of patients were in remission or had low disease activity at the time of infection.
Medications prior to infection included methotrexate (29%), TNFi (25%), and HCQ (19%); approximately 80% were not on glucocorticoids.
36% had no comorbidities, however 25% of patients were hypertensive.
36% had no comorbidities, however 25% of patients were hypertensive.
Presently, 100% of patients are alive, and 28% have resolved symptoms. 6% had ARDS, 4% sepsis, and 2% concomitant/secondary infection.
Most patients (58%) received no treatment for COVID-19 except supportive care.
Most patients (58%) received no treatment for COVID-19 except supportive care.
Our deepest gratitude to the providers who have taken time to enter this initial data. We will continue to provide updates as data comes in.
If you have a case to report, please go to our website: rheum-covid.org 
